Skip to main content
OpenTrials

Clinical trial condition

Anatomic Stage IV Breast Cancer AJCC v8

Explore clinical trials studying Anatomic Stage IV Breast Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

95 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Anatomic Stage IV Breast Cancer AJCC v8 trial results

Recruiting

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

NCT05422794

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +9 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Hospital - Long Island Mineola, New York, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
View Trial Details
Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

NCT04305834

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details

Related conditions